PubMed:10972144
Annnotations
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 12-21 | Glycan_Motif | denotes | A-antigen | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G71832QJ |
| T2 | 203-216 | Glycan_Motif | denotes | blood group A | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G58507AZ|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G17108EX |
| T4 | 376-385 | Glycan_Motif | denotes | A antigen | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G71832QJ |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 203-208 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
| T2 | 203-208 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
| T3 | 263-270 | http://purl.obolibrary.org/obo/MAT_0000526 | denotes | colonic |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-192 | Sentence | denotes | Deletion of A-antigen in a human cancer cell line is associated with reduced promoter activity of CBF/NF-Y binding region, and possibly with enhanced DNA methylation of A transferase promoter. |
| TextSentencer_T2 | 193-447 | Sentence | denotes | Employing blood group A- and A+ clones derived from the same parental colonic cancer cell lines, we studied the molecular mechanism of deletion/reduction vs. continuous expression of A antigen in A tumors, a crucial determinant of human tumor malignancy. |
| TextSentencer_T3 | 448-601 | Sentence | denotes | A- transferase mRNA level in one of the A- clones (A- SW480) was undetectable, while that in A+ SW480 was strongly detectable by semiquantitative RT-PCR. |
| TextSentencer_T4 | 602-885 | Sentence | denotes | Relatively lower (approximately 1/3) transcript level was detectable in another A- clone (A- HT29) in comparison to A+ HT29 by the same RT-PCR procedure, although none of these tumor cell lines showed detectable level of A transcript by Northern blotting or RNase protection methods. |
| TextSentencer_T5 | 886-964 | Sentence | denotes | Therefore, subsequent studies were performed employing A- vs. A+ SW480 clones. |
| TextSentencer_T6 | 965-1166 | Sentence | denotes | Deletion of A transcript in A- cells was not due to gene deletion, since Southern blot analysis showed equal presence of genomic DNA regardless of A- vs. A+ (SW480 or HT29) or B+ (KATOIII) tumor cells. |
| TextSentencer_T7 | 1167-1277 | Sentence | denotes | Two transcriptional control mechanisms leading to differences of A expression in SW480 cells are indicated. i. |
| TextSentencer_T8 | 1278-1448 | Sentence | denotes | Luciferase assay in A- and A+ SW480 cells showed that promoter activities of segments of 5' flanking sequence of ABO gene reflected transcript levels in these cell lines. |
| TextSentencer_T9 | 1449-1576 | Sentence | denotes | The enhancing activity of a 43 bp tandem repeat unit located between -3899 to -3618 was reduced in A- compared to A+ cells. ii. |
| TextSentencer_T10 | 1577-1675 | Sentence | denotes | Distinct differences in the pattern of CpG dinucleotide methylation were found in A- vs. A+ cells. |
| TextSentencer_T11 | 1676-1805 | Sentence | denotes | Therefore, the methylation process of A promoter DNA may be another important factor controlling A activity in SW480 tumor cells. |
| TextSentencer_T12 | 1806-2043 | Sentence | denotes | Since proliferation and motility of tumor cells are associated closely with A expression, transcription control mechanism for expression of A transferase as described above may be of crucial importance in defining human tumor malignancy. |
| T1 | 0-192 | Sentence | denotes | Deletion of A-antigen in a human cancer cell line is associated with reduced promoter activity of CBF/NF-Y binding region, and possibly with enhanced DNA methylation of A transferase promoter. |
| T2 | 193-447 | Sentence | denotes | Employing blood group A- and A+ clones derived from the same parental colonic cancer cell lines, we studied the molecular mechanism of deletion/reduction vs. continuous expression of A antigen in A tumors, a crucial determinant of human tumor malignancy. |
| T3 | 448-601 | Sentence | denotes | A- transferase mRNA level in one of the A- clones (A- SW480) was undetectable, while that in A+ SW480 was strongly detectable by semiquantitative RT-PCR. |
| T4 | 602-885 | Sentence | denotes | Relatively lower (approximately 1/3) transcript level was detectable in another A- clone (A- HT29) in comparison to A+ HT29 by the same RT-PCR procedure, although none of these tumor cell lines showed detectable level of A transcript by Northern blotting or RNase protection methods. |
| T5 | 886-964 | Sentence | denotes | Therefore, subsequent studies were performed employing A- vs. A+ SW480 clones. |
| T6 | 965-1166 | Sentence | denotes | Deletion of A transcript in A- cells was not due to gene deletion, since Southern blot analysis showed equal presence of genomic DNA regardless of A- vs. A+ (SW480 or HT29) or B+ (KATOIII) tumor cells. |
| T7 | 1167-1277 | Sentence | denotes | Two transcriptional control mechanisms leading to differences of A expression in SW480 cells are indicated. i. |
| T8 | 1278-1448 | Sentence | denotes | Luciferase assay in A- and A+ SW480 cells showed that promoter activities of segments of 5' flanking sequence of ABO gene reflected transcript levels in these cell lines. |
| T9 | 1449-1576 | Sentence | denotes | The enhancing activity of a 43 bp tandem repeat unit located between -3899 to -3618 was reduced in A- compared to A+ cells. ii. |
| T10 | 1577-1675 | Sentence | denotes | Distinct differences in the pattern of CpG dinucleotide methylation were found in A- vs. A+ cells. |
| T11 | 1676-1805 | Sentence | denotes | Therefore, the methylation process of A promoter DNA may be another important factor controlling A activity in SW480 tumor cells. |
| T12 | 1806-2043 | Sentence | denotes | Since proliferation and motility of tumor cells are associated closely with A expression, transcription control mechanism for expression of A transferase as described above may be of crucial importance in defining human tumor malignancy. |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 12-21 | https://glytoucan.org/Structures/Glycans/G71832QJ | denotes | A-antigen |
| T2 | 203-216 | https://glytoucan.org/Structures/Glycans/G17108EX | denotes | blood group A |
| T3 | 203-216 | https://glytoucan.org/Structures/Glycans/G58507AZ | denotes | blood group A |
| T4 | 376-385 | https://glytoucan.org/Structures/Glycans/G71832QJ | denotes | A antigen |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 263-277 | HP_0003003 | denotes | colonic cancer |
| T2 | 263-277 | HP_0100273 | denotes | colonic cancer |
| T3 | 271-277 | HP_0002664 | denotes | cancer |
| T4 | 391-397 | HP_0002664 | denotes | tumors |
| T5 | 430-435 | HP_0002664 | denotes | tumor |
| T6 | 779-784 | HP_0002664 | denotes | tumor |
| T7 | 1154-1159 | HP_0002664 | denotes | tumor |
| T8 | 1793-1798 | HP_0002664 | denotes | tumor |
| T9 | 1842-1847 | HP_0002664 | denotes | tumor |
| T10 | 2026-2031 | HP_0002664 | denotes | tumor |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 98-101 | gene:10153 | denotes | CBF |
| T1 | 33-39 | disease:C0006826 | denotes | cancer |
| T2 | 98-101 | gene:10153 | denotes | CBF |
| T3 | 33-39 | disease:C1306459 | denotes | cancer |
| T4 | 169-182 | gene:28 | denotes | A transferase |
| T5 | 33-39 | disease:C0006826 | denotes | cancer |
| T6 | 169-182 | gene:28 | denotes | A transferase |
| T7 | 33-39 | disease:C1306459 | denotes | cancer |
| R1 | T0 | T1 | associated_with | CBF,cancer |
| R2 | T2 | T3 | associated_with | CBF,cancer |
| R3 | T4 | T5 | associated_with | A transferase,cancer |
| R4 | T6 | T7 | associated_with | A transferase,cancer |
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 203-216 | Glycan | denotes | blood group A | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00066MO |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 203-208 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |
| T3 | 263-270 | Body_part | denotes | colonic | http://purl.obolibrary.org/obo/MAT_0000526 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 33-39 | Phenotype | denotes | cancer | HP:0002664 |
| T2 | 263-277 | Phenotype | denotes | colonic cancer | HP:0003003 |
| T3 | 430-435 | Phenotype | denotes | tumor | HP:0002664 |
| T4 | 779-784 | Phenotype | denotes | tumor | HP:0002664 |
| T5 | 1154-1159 | Phenotype | denotes | tumor | HP:0002664 |
| T6 | 1793-1798 | Phenotype | denotes | tumor | HP:0002664 |
| T7 | 1842-1847 | Phenotype | denotes | tumor | HP:0002664 |
| T8 | 2026-2031 | Phenotype | denotes | tumor | HP:0002664 |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 33-39 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
| T2 | 263-277 | Disease | denotes | colonic cancer | http://purl.obolibrary.org/obo/MONDO_0021063 |
| T3 | 391-397 | Disease | denotes | tumors | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T4 | 430-435 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T5 | 779-784 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T6 | 1154-1159 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T7 | 1793-1798 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T8 | 1842-1847 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T9 | 2026-2031 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
GlyCosmos15-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 33-39 | Phenotype | denotes | cancer | HP:0002664 |
| T2 | 271-277 | Phenotype | denotes | cancer | HP:0002664 |
| T3 | 430-435 | Phenotype | denotes | tumor | HP:0002664 |
| T4 | 779-784 | Phenotype | denotes | tumor | HP:0002664 |
| T5 | 1154-1159 | Phenotype | denotes | tumor | HP:0002664 |
| T6 | 1793-1798 | Phenotype | denotes | tumor | HP:0002664 |
| T7 | 1842-1847 | Phenotype | denotes | tumor | HP:0002664 |
| T8 | 2026-2031 | Phenotype | denotes | tumor | HP:0002664 |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-192 | Sentence | denotes | Deletion of A-antigen in a human cancer cell line is associated with reduced promoter activity of CBF/NF-Y binding region, and possibly with enhanced DNA methylation of A transferase promoter. |
| T2 | 193-447 | Sentence | denotes | Employing blood group A- and A+ clones derived from the same parental colonic cancer cell lines, we studied the molecular mechanism of deletion/reduction vs. continuous expression of A antigen in A tumors, a crucial determinant of human tumor malignancy. |
| T3 | 448-601 | Sentence | denotes | A- transferase mRNA level in one of the A- clones (A- SW480) was undetectable, while that in A+ SW480 was strongly detectable by semiquantitative RT-PCR. |
| T4 | 602-885 | Sentence | denotes | Relatively lower (approximately 1/3) transcript level was detectable in another A- clone (A- HT29) in comparison to A+ HT29 by the same RT-PCR procedure, although none of these tumor cell lines showed detectable level of A transcript by Northern blotting or RNase protection methods. |
| T5 | 886-964 | Sentence | denotes | Therefore, subsequent studies were performed employing A- vs. A+ SW480 clones. |
| T6 | 965-1166 | Sentence | denotes | Deletion of A transcript in A- cells was not due to gene deletion, since Southern blot analysis showed equal presence of genomic DNA regardless of A- vs. A+ (SW480 or HT29) or B+ (KATOIII) tumor cells. |
| T7 | 1167-1277 | Sentence | denotes | Two transcriptional control mechanisms leading to differences of A expression in SW480 cells are indicated. i. |
| T8 | 1278-1448 | Sentence | denotes | Luciferase assay in A- and A+ SW480 cells showed that promoter activities of segments of 5' flanking sequence of ABO gene reflected transcript levels in these cell lines. |
| T9 | 1449-1576 | Sentence | denotes | The enhancing activity of a 43 bp tandem repeat unit located between -3899 to -3618 was reduced in A- compared to A+ cells. ii. |
| T10 | 1577-1675 | Sentence | denotes | Distinct differences in the pattern of CpG dinucleotide methylation were found in A- vs. A+ cells. |
| T11 | 1676-1805 | Sentence | denotes | Therefore, the methylation process of A promoter DNA may be another important factor controlling A activity in SW480 tumor cells. |
| T12 | 1806-2043 | Sentence | denotes | Since proliferation and motility of tumor cells are associated closely with A expression, transcription control mechanism for expression of A transferase as described above may be of crucial importance in defining human tumor malignancy. |
GlyCosmos15-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 33-39 | Disease | denotes | cancer | MONDO:0004992 |
| T2 | 263-277 | Disease | denotes | colonic cancer | MONDO:0002032|MONDO:0005575|MONDO:0021063 |
| T5 | 430-435 | Disease | denotes | tumor | MONDO:0005070 |
| T6 | 436-446 | Disease | denotes | malignancy | MONDO:0004992 |
| T7 | 779-784 | Disease | denotes | tumor | MONDO:0005070 |
| T8 | 1154-1159 | Disease | denotes | tumor | MONDO:0005070 |
| T9 | 1793-1798 | Disease | denotes | tumor | MONDO:0005070 |
| T10 | 1842-1847 | Disease | denotes | tumor | MONDO:0005070 |
| T11 | 2026-2031 | Disease | denotes | tumor | MONDO:0005070 |
| T12 | 2032-2042 | Disease | denotes | malignancy | MONDO:0004992 |
GlyCosmos15-Taxon
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 27-32 | Organism | denotes | human | 9606 |
| T2 | 424-429 | Organism | denotes | human | 9606 |
| T3 | 2020-2025 | Organism | denotes | human | 9606 |
GlyCosmos15-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 203-208 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
| T2 | 1355-1363 | Body_part | denotes | segments | http://purl.obolibrary.org/obo/UBERON_0000914 |
GlyCosmos15-FMA
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 203-208 | Body_part | denotes | blood | FMA:9670 |
GlyCosmos15-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 203-208 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/MAT_0000315 |
| T2 | 263-270 | Body_part | denotes | colonic | http://purl.obolibrary.org/obo/MAT_0000526 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 27-32 | OrganismTaxon | denotes | human | 9606 |
| T2 | 424-429 | OrganismTaxon | denotes | human | 9606 |
| T3 | 2020-2025 | OrganismTaxon | denotes | human | 9606 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 203-208 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
| T2 | 1355-1363 | Body_part | denotes | segments | http://purl.obolibrary.org/obo/UBERON_0000914 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 33-44 | Cell | denotes | cancer cell | http://purl.obolibrary.org/obo/CL:0001064 |
| T2 | 271-282 | Cell | denotes | cancer cell | http://purl.obolibrary.org/obo/CL:0001064 |
| T3 | 779-789 | Cell | denotes | tumor cell | http://purl.obolibrary.org/obo/CL:0001063 |
| T4 | 1154-1165 | Cell | denotes | tumor cells | http://purl.obolibrary.org/obo/CL:0001063 |
| T5 | 1793-1804 | Cell | denotes | tumor cells | http://purl.obolibrary.org/obo/CL:0001063 |
| T6 | 1842-1853 | Cell | denotes | tumor cells | http://purl.obolibrary.org/obo/CL:0001063 |